Samantha Beck

Samantha Beck

Auto-generated profile, based on publicly available information

Samantha Beck

Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina (UNC), Chapel Hill, North Carolina

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2025 in Blood Global Hematology
Verified
Journal Article
Open access
SBSamantha Beck
Samantha Beck
ACAbigail Cowell
Abigail Cowell
SRSophia M. Roush
Sophia M. Roush
MMMarriam Mponda
Marriam Mponda
EKEdwards Kasonkanji
Edwards Kasonkanji
YFYuri Fedoriw
Yuri Fedoriw
Classic Hodgkin lymphoma (cHL) is a hematolymphoid neoplasm highly associated with Epstein-Barr virus (EBV), and molecular differences by tumor EBV status have been well characterized. Additionally, people with HIV (PWH) are 5 times as likely to develop cHL, and cHL in PWH is nearly exclusively EBV associated. However, there are limited published molecular characterizations of cHL arising in PWH (HIV+ cHL). This gap is particularly impactful in the Global South where cancer mortality and HIV prevalence are high. In this study, we evaluated the whole exome, transcriptome, and T-cell receptor (TCR) repertoire of an HIV-inclusive cohort of patients with cHL from Malawi. HIV+ cHL had increased tumor mutational burden compared with cHL in people without HIV (HIV− cHL). EBV positive (EBV+)/HIV− tumors exhibited a distinct transcriptional profile compared with EBV−/HIV− and EBV+/HIV+. Additionally, both EBV and HIV were associated with cellular composition changes within the tumor microenvironment, including increases in memory B cells and CD8+ T cells compared with EBV− and HIV− cHL. TCR clonality was increased in EBV+ cHL, with trend towards further increase in clonality in HIV+. Through a multiomic approach of a well-characterized, HIV-inclusive cHL cohort from one of the most resource-limited countries in the world, we were able to recapitulate known, and identify novel molecular differences by HIV and EBV status.

22 October 2026
Verified
Other
Open access
JCJenny Coelho
Jenny Coelho
SRSophia M. Roush
Sophia M. Roush
SBSamantha Beck
Samantha Beck
AWAlbert Wielgus
Albert Wielgus
AXAlexander M. Xu
Alexander M. Xu
YFYuri Fedoriw
Yuri Fedoriw
Supplemental Figure S7. Heatmap of differentially expressed genes by PCA-based clusters of HIV+ tumors.

22 October 2026
Verified
Other
Open access
JCJenny Coelho
Jenny Coelho
SRSophia M. Roush
Sophia M. Roush
SBSamantha Beck
Samantha Beck
AWAlbert Wielgus
Albert Wielgus
AXAlexander M. Xu
Alexander M. Xu
YFYuri Fedoriw
Yuri Fedoriw
Supplemental Figure S4. A) Cellular composition of IMC-derived cell type neighborhoods. Stacked bar chart shows the proportional cellular compositions of the six identified cell type neighborhoods. B) Violin plot of the proportional differences of the six cell-type neighborhoods by HIV/ART status. Each dot represents the proportion of the cell-type neighborhood in one ROI from the IMC tissue microarray. The black bar represents the median. P-values are calculated by Wilcoxon rank-sum tests.

22 October 2026
Verified
Other
Open access
JCJenny Coelho
Jenny Coelho
SRSophia M. Roush
Sophia M. Roush
SBSamantha Beck
Samantha Beck
AWAlbert Wielgus
Albert Wielgus
AXAlexander M. Xu
Alexander M. Xu
YFYuri Fedoriw
Yuri Fedoriw
Supplemental Figure S13. Exploratory analysis of tumor-intrinsic gene expression, subclonal architecture, and pseudotime trajectories by tumor mutational burden.

22 October 2026
Verified
Other
Open access
JCJenny Coelho
Jenny Coelho
SRSophia M. Roush
Sophia M. Roush
SBSamantha Beck
Samantha Beck
AWAlbert Wielgus
Albert Wielgus
AXAlexander M. Xu
Alexander M. Xu
YFYuri Fedoriw
Yuri Fedoriw
Supplemental Figure S12. Pseudotime complexity by HIV/ART status.

22 October 2026
Verified
Other
Open access
JCJenny Coelho
Jenny Coelho
SRSophia M. Roush
Sophia M. Roush
SBSamantha Beck
Samantha Beck
AWAlbert Wielgus
Albert Wielgus
AXAlexander M. Xu
Alexander M. Xu
YFYuri Fedoriw
Yuri Fedoriw
IMC Antibody Panel per reviewer request from previous publication (ref 6)